Institutional investors purchased a net $1.7 million shares of ICLR during the quarter ended December 2016 and now own 94.02% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.2 Million shares of ICON PLC
SPF BEHEER BV Bought 696.5 Thousand shares of ICON PLC